spacer
home > ict > winter 2008 > we can be heroes
PUBLICATIONS
International Clinical Trials

We Can be Heroes

Describing the public health benefits of promoting patient participation, Kenneth Getz at the Tufts Center for the Study of Drug Development, James Kremidas at Eli Lilly and Company, Elizabeth Carfioli of Ogilvy Healthworld Consulting (US) and Rachael Butlin at Fast4wD Ogilvy (UK) challenge public perceptions of clinical trials

A GLOBAL PROBLEM

Clinical research is essential for developing treatments that improve public health. Without it, many medical advances that ease human suffering, offer better treatment options and even cure life-threatening illnesses would never have been introduced.

Despite the high importance of clinical research and the access to investigational new treatments that it affords, patient participation rates are low. As few as 10 per cent of eligible patients in the US participate in clinical trials (1) – a figure that is only slightly higher than other parts of the world, which sit at an overall participation rate of only six to eight per cent of eligible patients (2). Pharmaceutical companies are increasingly investing in communication programmes to ensure awareness and knowledge of the studies that they are conducting and, ultimately, to increase patient participation in clinical trials.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Kenneth A Getz is the chairman of CISCRP – a non-profit organisation that he founded to educate and raise public awareness of the clinical research enterprise – and a Senior Research fellow at the Tufts Center for the Study of Drug Development, where he studies R&D management and operating models, investigative sites, outsourcing and study volunteer trends and policies. A wellknown speaker, Ken has published over 150 articles and two books, and serves on a number of corporate and non-profit boards. Ken is also the founder and former CEO of CenterWatch, a leading publisher in the clinical trials industry.

Jim Kremidas leads the clinical trial patient recruitment and retention efforts at Eli Lilly and Company. His role focuses on predicting and accelerating the enrolment rates for all corporate studies. Jim is a member of the Steering Committee for the Center for Information and Study on Clinical Research Participation (CISCRP).

Elizabeth Carfioli has over 10 years of experience in the strategic planning and implementation of global patient recruitment and retention programmes, having worked for both agencies and sponsors. She is currently working for Ogilvy Healthworld Consulting, providing strategic counsel to clients on improving internal processes for enrolment acceleration.

Rachael Butlin is an Account Manager at Fast4wD Ogilvy, a specialised global patient recruitment and retention company. She has a business and marketing background, and has combined this experience with her knowledge of study stakeholder needs in outlining bespoke global programmes for a number of top pharmaceutical study sponsors. Her expertise spans numerous therapy areas including pain, oncology and mental health.

spacer
Kenneth A Getz
spacer
spacer
spacer
Jim Kremidas
spacer
spacer
spacer
Elizabeth Carfioli
spacer
spacer
spacer
Rachael Butlin
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo maintains its steady growth.

According to the data obtained by WACD, the international air cargo information provider, in May; Turkish Cargo, the global air cargo brand providing service to 124 countries around the world, increased its tonnage rate by 7.1 percent, and grew substantially across the industry which shrank by 5.1 percent in the global air cargo market.
More info >>

White Papers

e-tools enhance clinical trial performance

e-novex

In today’s ever-evolving medical business, technological changes require innovation to meet growing market demands and to bring about advances in the industry. One such development currently taking place in the field of clinical research is how e-tools are initiating a boost in the productivity of clinical trials.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement